Lenvatinib-Induced Acute Pancreatitis in a Patient with Metastatic Thyroid Cancer: A Case Report

BACKGROUND: Lenvatinib, a novel multi-target tyrosine kinase inhibitor, has been approved for treating differentiated thyroid cancer. Herein, we describe a rare case of acute pancreatitis that developed during lenvatinib treatment in a 65-year-old man with recurrent thyroid cancer. CASE PRESENTATION...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hong Jun, Han, Jae Joon, Maeng, Chi Hoon, Baek, Sun Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522403/
https://www.ncbi.nlm.nih.gov/pubmed/33061538
http://dx.doi.org/10.2147/IJGM.S272375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522403/
https://www.ncbi.nlm.nih.gov/pubmed/33061538
http://dx.doi.org/10.2147/IJGM.S272375

Ejemplares similares